Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-09-11
1998-11-03
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514601, 514605, 514631, 514636, 514637, 514824, 514866, 514921, 514929, 564 98, 564 99, 564225, 564236, 564237, 564240, 564243, A61K 3118, A61K 31155, C07C27912, C07C31105
Patent
active
058309179
ABSTRACT:
There is disclosed a novel amino alcohol amine derivatives of L-N.sup.6 -(1-iminoethyl)lysine, pharmaceutical compositions containing these novel compounds, and to their use in therapy, in particular their use as nitric oxide synthase inhibitors.
REFERENCES:
patent: 3499927 (1970-03-01), Badcock et al.
patent: 4713369 (1987-12-01), Suber
patent: 5059712 (1991-10-01), Griffith
patent: 5081148 (1992-01-01), Braquet et al.
patent: 5132453 (1992-07-01), Griffith
patent: 5196450 (1993-03-01), Sjoerdsma et al.
patent: 5242947 (1993-09-01), Cherksey et al.
patent: 5273875 (1993-12-01), Griffith
patent: 5281627 (1994-01-01), Griffith
patent: 5362744 (1994-11-01), Purchase, Jr. et al.
patent: 5380945 (1995-01-01), Murad et al.
Gould et al., "Nucleoside Intermediates in Blasticidin S Biosynthesis Identified by the In Vivo Use of Enzyme Inhibitors", Can. J. Chem., vol. 72, pp. 6-11, 1994.
Tsunematsu et al., ".beta.-Naphthylamides of Guanidinophenyl Amino Acids as Substrates of Aminopeptidases", Chem. Pharm. Bull., vol. 36, No. 3, pp. 1205-1209, 1988.
Funabashi et al., "A New Atni-MRSA Dipeptide, TAN-1057 A", Tetrahedron, vol. 49, No. 1, pp. 13-28, 1993.
Prabhakaran et al., "Studies on Nitrogen Metabolism Using .sup.13 C NMR Spectroscopy. 5..sup.1 Metabolism of L-.alpha.-Arginine in the Biosynthesis of Blasticidin S", Tetrahedron, vol. 27, No. 33, pp. 3815-3818, 1986.
Stuehr et al., "Mammalian Nitric Oxide Syntheases", Advances in Enzymology, vol. 65, 1992, (p. 317).
Plapp et al., "Determination of .epsilon.-Acetimidyllysine in Proteins" Analytical Biochemistry, vol. 62, pp. 291-294, 1974.
Rees et al., "Characterization of Three Inhibitors of Endothelial Nitric Oxide Synthase in vitro and in vivo", Br. J. Pharmacol., vol. 101, pp. 746-752, 1990.
Proudfoot et al., "Conformation-directed Recombination of Enzyme-activated Peptide Fragments: A Simple and Efficient Means to Protein Engineering", J. Bio. Chem., vol. 264, No. 15, pp. 8764-8770, 1989.
Palacios, et al., "Nitric Oxide from L-Arginine Stimulates the Soluble Guanylate Cyclase in Adrenal Glands", Biochemical and Biophysical Research Communications, vol. 165, No. 2, pp. 802-809, 1989.
Knowles et al., "Kinetic Characteristics of Nitric Oxide Synthase from Rat Brain", Biochem. J., vol. 269, pp. 207-210, 1990.
CA 107, 40336y, 1987.
CA 63, 5641d, 1995.
CA 97, 38442m, 1982.
CA 76, 43768t, 1972.
CA 118, 72838g, 1993.
CA 64, 17593h, 1966.
CA 115, 29868t, 1991.
CA 104, 202858, 1986.
CA 110, 228216, 1989.
CA 105, 225818, 1986.
Morimoto et al., ZA 8502512, cited in Chem. Abst., 105:225818, 1986.
Hallinan E. Ann
Moore William M.
Bennett Dennis A.
G. D. Searle & Co.
O'Sullivan Peter
LandOfFree
L-N.sup.6 -(1-iminoethyl) lysine derivatives useful as nitric ox does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with L-N.sup.6 -(1-iminoethyl) lysine derivatives useful as nitric ox, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-N.sup.6 -(1-iminoethyl) lysine derivatives useful as nitric ox will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689563